Skip to main content

Posts

NCI-H292 Cell Line

The NCI-H292 cell line was established from the lymph node metastasis lung tissue of a 32-year-old female patient with mucoepidermoid pulmonary carcinoma. NCI-H292 cells are tumorigenic cells that display an epithelial morphology and adherent cultural properties, able to retain their mucoepidermoid characteristics. NCI-H292 produces keratin and vimentin, and is also susceptible to Hepatitis B virus. NCI-H292 cells are suitable transfection hosts to study lung cancer and Altogen Biosystems offers an optimized  NCI-H292 reagent to transfect NCI-H292 cells.
Post a Comment
Read more
Recent posts

Virus-Associated Lung Cancer Research Tools from Altogen

Altogen Biosystems is a quality manufacturer and laboratory for biological laboratories. Custom biological opportunities and additional preclinical items include siRNA screening, drug testing, 28-day generation of stably-transfected cells, liposome encapsulation and more. Dedicated to benefiting laboratories with cutting-edge and excellent services, Altogen Biosystems aims to improve modern laboratory technologies. Visit Altogen for a lung xenograft model and additional information to aid in preclinical research and drug evaluations.
Post a Comment
Read more

The NCI-H292 Cell Line for Lung Cancer Drug Development

Derived from a young human female, the NCI-H292 cell line comes from the mucoepidermoid pulmonary carcinoma of a metastasized lung cancer found in the lymph node. The cell line has been used for viral research and related drug development tied to infection by the herpes simplex, mumps, and measles viruses. With an epithelial morphology, NCI-H292 cells are easy to grow in culture and modify genetically using optimized transfection reagents . Therapies relying on gene-silencing via siRNA transfection or the introduction of important protein sequences into cells can be tested quickly and efficiently in the cell line, granting quick and reliable results.
Post a Comment
Read more

NCI-H292 Transfection Reagent (Lung Carcinoma, CRL1848)

The NCI-H292 cell line was established from the lymph node metastasis  lung cells derived from a female patient suffering from mucoepidermoid pulmonary carcinoma (lung cancer). The cells exhibit an epithelial morphology, test negative for L-DOPA decarboxylase and ultimately demonstrate similar characteristics as non-carcinogenic cells do. The NCI-H292 cells have shown susceptibility to the Hepatitis B virus, making it a useful biomedical research model. Altogen Biosystems manufactures a high efficiency transfection reagent to further examine the properties of the NCI-H292 cell line for lung cancer treatments. Transfection Reagent for NCI-H292 Cells (Lung Carcinoma Cells, CRL-1848)
Read more